Sandoz

Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
Amgen and Sandoz Square Off Over a Biosimilar Application
WSJ Pharmalot
Mon, 11/3/14 - 11:45 am
Amgen
Sandoz
biosimilars
Neupogen
Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft
FDA Law Blog
Thu, 10/30/14 - 05:43 pm
Amgen
Sandoz
Neupogen
biosimilars
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Fri, 08/8/14 - 09:34 am
biosimilars
Sandoz
Novartis
FDA
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Mon, 07/21/14 - 10:43 am
Allergan
layoffs
Anacor
Sinovac Biotech
Kerydin
earnings
China
Sandoz
vaccines
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thu, 06/19/14 - 05:47 pm
NUVIGIL
patents
Teva Pharmaceuticals
Sandoz
Apotex
Mylan Labs
Actavis
Lupin
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
biotech
generics
Amgen
Roche
Biogen Idec
Eli Lilly
Bristol-Myers Squibb
Sanofi
Novartis
Sandoz
Omnitrope
Genotropin
Acura Pharma announces settlement of patent litigation with Sandoz
The Fly on the Wall
Thu, 05/22/14 - 08:28 am
Sandoz
Novartis
Acura Pharmaceuticals
patents
Aversion
Oxceta
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thu, 05/15/14 - 07:35 am
Teva
FDA
generics
Copaxone
Mylan Labs
Novartis
Sandoz
multiple sclerosis
Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Mon, 04/14/14 - 07:08 pm
Teva
Copaxone
MS
multiple sclerosis
Momenta
generics
Sandoz
Mylan
Novartis names two new leaders to growth drivers Alcon, Sandoz
Fierce Pharma
Wed, 04/9/14 - 09:43 pm
Alcon
Sandoz
Novartis
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Mon, 03/31/14 - 11:00 am
Supreme Court
MS
multiple sclerosis
Copaxone
Teva Pharmaceuticals
Sandoz
Mylan
Momenta
Novartis CEO predicts generic industry fallout as quality takes center stage
Fierce Pharma Manufacturing
Fri, 03/21/14 - 08:49 am
Sandoz
Novartis
Joe Jimenez
generics
drug manufacturing
Cadence: Patent Settlement With Sandoz Increases Confidence That Ofirmev Will Have Exclusivity Through December 6, 2020
Seeking Alpha
Fri, 01/31/14 - 08:45 am
Cadence Pharmaceuticals
Sandoz
Ofirmev
Exela Pharma Sciences
Sandoz starts late-stage trial with copy of AbbVie's Humira drug
Yahoo/AP
Wed, 12/18/13 - 05:14 pm
Sandoz
generics
Humira
AbbVie
biosimilars
Novartis
Shire agrees to supply Adderall XR generic to Sandoz
Reuters
Mon, 12/2/13 - 08:40 am
Shire
generics
Sandoz
Novartis
ADHD
Adderall XR
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Mon, 11/25/13 - 09:01 am
Europe
JNJ
Novartis
pay-for-delay
generics
Sandoz
Fentanyl
pain patches
Glaxo Declines as FDA Clears Path for Advair Rivals
Bloomberg
Tue, 09/10/13 - 10:41 am
GSK
Advair
FDA
COPD
asthma
Sandoz
Actavis
Mylan
generics
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Mon, 06/24/13 - 10:44 am
Amgen
Enbrel
generics
Sandoz
Novartis
chronic plaque psoriasis
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Fri, 05/31/13 - 09:07 am
Takeda
Biogen Idec
intellectual property
Novartis
Dexilant
generics
Sandoz
Tecfidera
Impax Laboratories

Pages